@article{Mueller_2022,<br/><span class="tab"></span> title={Neuropsychiatric Drugs Against COVID-19: What is the Clinical
                    Evidence?},<br/><span class="tab"></span> volume={55},<br/><span class="tab"></span> ISSN={1439-0795},<br/><span class="tab"></span> url={http://dx.doi.org/10.1055/a-1717-2381},<br/><span class="tab"></span> DOI={10.1055/a-1717-2381},<br/><span class="tab"></span> number={01},<br/><span class="tab"></span> journal={Pharmacopsychiatry},<br/><span class="tab"></span> publisher={Georg Thieme Verlag KG},<br/><span class="tab"></span> author={Mueller,<br/><span class="tab"></span> Juliane K. and Riederer,<br/><span class="tab"></span> Peter and Müller,<br/><span class="tab"></span> Walter E.},<br/><span class="tab"></span> year={2022},<br/><span class="tab"></span> month=jan,<br/><span class="tab"></span> pages={7–15} }